Ascendis Pharma A/S at JPMorgan Healthcare Conference (Virtual) Transcript - Thomson StreetEvents

Ascendis Pharma A/S at JPMorgan Healthcare Conference (Virtual) Transcript

Ascendis Pharma A/S at JPMorgan Healthcare Conference (Virtual) Transcript - Thomson StreetEvents
Ascendis Pharma A/S at JPMorgan Healthcare Conference (Virtual) Transcript
Published Jan 10, 2022
Published Jan 10, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ASND.OQ presentation 10-Jan-22 8:00pm GMT

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Ascendis Pharma A/S
Ticker
ASND.OQ
Time
8:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst : Great. Well, thanks, Jan, for that presentation. Just as a reminder to everyone watching, if you want to ask a question, you can hit blue Ask a Question button that will send the questions to me. Maybe just start out, I appreciate the details on the SKYTROFA launch progress. I think one of the slides said that coverage is at 28% now. Where do you envision that going over the rest of '22?

Question: Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst : It's related to that, you also -- you talked about the number of prescribers and patients getting on drug. How many of the initial patients are going on to free drug?

Question: Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst : Switching to TransCon PTH, and we're looking forward to that Phase III data in the first quarter. Any chance that you can refine when in the first quarter we should expect those top line results?

Question: Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst : And I guess when we see those topline results, can you just walk through the primary and key secondary endpoints in that study? And maybe how they compare or differ from the primary endpoint in the NATPARA Phase III study for 1 folks inevitably kind of line up those 2 data sets?

Question: Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst : Okay. And we're just about out of time, but I don't know if you have a short way of answering this question. When TransCon CNP Phase II reads out in the fourth quarter, what should we -- like how should we think about a clinically meaningful improvement in annualized growth velocity. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JANUARY 10, 2022 / 8:00PM, ASND.OQ - Ascendis Pharma A/S at JPMorgan Healthcare Conference (Virtual)

Question: Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst : Great. So we are out of time, so we'll leave it there. Thank you very much, and thanks, everyone, for listening in. Unidentified Company Representative Thanks so much.

Table Of Contents

Ascendis Pharma A/S Q2 2022 Earnings Call Transcript – 2022-08-10 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 10-Aug-22 8:30pm GMT

Ascendis Pharma A/S at Bank of America Healthcare Conference Transcript – 2022-05-12 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 12-May-22 5:40pm GMT

Ascendis Pharma A/S Q1 2022 Earnings Call Transcript – 2022-05-11 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 11-May-22 8:30pm GMT

Ascendis Pharma A/S Announces Phase 3 PaTHway Trial Results Conference Call Transcript – 2022-03-14 – US$ 54.00 – Edited Transcript of ASND.OQ conference call or presentation 14-Mar-22 12:00pm GMT

Ascendis Pharma A/S Q4 2021 Earnings Call Transcript – 2022-03-02 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 2-Mar-22 9:30pm GMT

Ascendis Pharma A/S R&D Update Transcript – 2021-12-14 – US$ 54.00 – Edited Transcript of ASND.OQ conference call or presentation 14-Dec-21 2:00pm GMT

Ascendis Pharma A/S Q3 2021 Earnings Call Transcript – 2021-11-10 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 10-Nov-21 9:30pm GMT

Ascendis Pharma A/S at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-15 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 15-Sep-21 4:30pm GMT

Ascendis Pharma A/S Q2 2021 Earnings Call Transcript – 2021-08-25 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 25-Aug-21 8:30pm GMT

Ascendis Pharma A/S Q1 2021 Earnings Call Transcript – 2021-05-27 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 27-May-21 8:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ascendis Pharma A/S at JPMorgan Healthcare Conference (Virtual) Transcript" Jan 10, 2022. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Ascendis-Pharma-A-S-at-JPMorgan-Healthcare-Conference-Virtual-T15086946>
  
APA:
Thomson StreetEvents. (2022). Ascendis Pharma A/S at JPMorgan Healthcare Conference (Virtual) Transcript Jan 10, 2022. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Ascendis-Pharma-A-S-at-JPMorgan-Healthcare-Conference-Virtual-T15086946>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.